The observed association of the impact of CDK8 in cancers with low mutation burden is reasonable, since CDK8 regulates transcription and may be expected therefore to have a greater impact in those cancers that are driven primarily by changes in gene expression rather than mutations. This evidence concerns the gene CDK8 and cancer.